Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.04B |
| 2 |
Gaotu Techedu
GOTU
|
+$1.03B |
| 3 |
Visa
V
|
+$749M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$517M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$515M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.43B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.58B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$759M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$643M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Healthcare | 7.67% |
| 4 | Financials | 7.46% |
| 5 | Communication Services | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
PUT
Neurocrine Biosciences
NBIX
$16.6B
| $14.9M | ﹤0.01% |
155,200
+89,900
| +138% | +$8.68M |
|
2102
ArcelorMittal
MT
$54.8B
| $14.9M | ﹤0.01% |
648,993
-1,179,218
| -65% | -$20.6M |
|
2103
Erie Indemnity
ERIE
$13.4B
| $14.9M | ﹤0.01% |
60,494
-192
| -0.3% | -$44.8K |
|
2104
PUT
MSCI
MSCI
$40.9B
| $14.8M | ﹤0.01% |
33,200
+6,900
| +26% | +$2.71M |
|
2105
Primoris Services
PRIM
$4.45B
| $14.8M | ﹤0.01% |
536,740
+144,326
| +37% | +$3.32M |
|
2106
Warrior Met Coal
HCC
$4.8B
| $14.8M | ﹤0.01% |
694,397
-537,690
| -44% | -$9.45M |
|
2107
Vir Biotechnology
VIR
$1.5B
| $14.8M | ﹤0.01% |
552,233
+146,862
| +36% | +$4.77M |
|
|
INFN
2108
DELISTED
Infinera Corporation Common Stock
INFN
| $14.8M | ﹤0.01% |
1,410,300
+156,758
| +13% | +$1.24M |
|
2109
HNI Corp
HNI
$3.56B
| $14.8M | ﹤0.01% |
428,123
-28,404
| -6% | -$1.02M |
|
|
ROIC
2110
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $14.7M | ﹤0.01% |
1,100,686
+186,581
| +20% | +$2.28M |
|
2111
AptarGroup
ATR
$8.66B
| $14.7M | ﹤0.01% |
107,616
-29,257
| -21% | -$3.63M |
|
2112
M/I Homes
MHO
$3.79B
| $14.7M | ﹤0.01% |
332,560
-63,288
| -16% | -$2.86M |
|
2113
Sonoco
SON
$5.68B
| $14.7M | ﹤0.01% |
248,525
-105,072
| -30% | -$5.91M |
|
2114
Four Corners Property Trust
FCPT
$2.75B
| $14.7M | ﹤0.01% |
493,948
-247,882
| -33% | -$6.94M |
|
2115
Regal Rexnord
RRX
$11.9B
| $14.7M | ﹤0.01% |
119,635
-31,019
| -21% | -$3.43M |
|
|
KRTX
2116
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $14.7M | ﹤0.01% |
144,516
+52,591
| +57% | +$4.87M |
|
2117
Central Pacific Financial
CPF
$1.01B
| $14.7M | ﹤0.01% |
771,802
-57,779
| -7% | -$941K |
|
2118
Vanguard ESG US Stock ETF
ESGV
$13.6B
| $14.7M | ﹤0.01% |
208,796
+10,720
| +5% | +$708K |
|
2119
VanEck Pharmaceutical ETF
PPH
$935M
| $14.6M | ﹤0.01% |
220,127
| – | – |
|
2120
Advanced Drainage Systems
WMS
$11.3B
| $14.6M | ﹤0.01% |
174,776
+21,425
| +14% | +$1.52M |
|
2121
Empire State Realty Trust
ESRT
$840M
| $14.6M | ﹤0.01% |
1,566,416
-779,262
| -33% | -$6.15M |
|
2122
PUT
Centene
CNC
$32.6B
| $14.6M | ﹤0.01% |
242,900
+130,000
| +115% | +$8.26M |
|
2123
PUT
Deere & Co
DE
$169B
| $14.5M | ﹤0.01% |
54,000
+8,300
| +18% | +$2.06M |
|
2124
Axsome Therapeutics
AXSM
$10.9B
| $14.5M | ﹤0.01% |
177,796
-152,661
| -46% | -$11.4M |
|
2125
Canadian Solar
CSIQ
$1.07B
| $14.5M | ﹤0.01% |
282,602
-234,150
| -45% | -$9.6M |
|
Similar funds
Goldman Sachs's Q4 2020 Portfolio in Review
As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.
- Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
- Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
- Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
- Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
- Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
- Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
- Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.